{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T13:19:57Z","timestamp":1648646397933},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:00:00Z","timestamp":1500076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00277-017-3062-2","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T02:01:07Z","timestamp":1500084067000},"page":"1563-1568","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination"],"prefix":"10.1007","volume":"96","author":[{"given":"Neeraj","family":"Saini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajneesh","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Cerny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,15]]},"reference":[{"key":"3062_CR1","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V65.6.1325.bloodjournal6561325","volume":"65","author":"HJ Deeg","year":"1985","unstructured":"Deeg HJ, Storb R, Thomas ED, Flournoy N, Kennedy MS, Banaji M, Appelbaum FR, Bensinger WI, Buckner CD, Clift RA (1985) Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 65:1325\u20131334","journal-title":"Blood"},{"key":"3062_CR2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM199310213291703","volume":"329","author":"NJ Chao","year":"1993","unstructured":"Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O\u2019Donnell MR, Parker PM (1993) Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 329:1225\u20131230","journal-title":"N Engl J Med"},{"key":"3062_CR3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1034\/j.1600-065X.2001.1820108.x","volume":"182","author":"EH Field","year":"2001","unstructured":"Field EH, Matesic D, Rigby S, Fehr T, Rouse T, Gao Q (2001) CD4+CD25+ regulatory cells in acquired MHC tolerance. Immunol Rev 182:99\u2013112","journal-title":"Immunol Rev"},{"key":"3062_CR4","doi-asserted-by":"crossref","unstructured":"Kingsley CI, Karim M, Bushell AR, Wood KJ (2002) CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol (Baltimore, Md\u00a0: 1950) 168:1080\u20131086","DOI":"10.4049\/jimmunol.168.3.1080"},{"key":"3062_CR5","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","volume":"106","author":"E Zorn","year":"2005","unstructured":"Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, Bellucci R, Alyea EP, Antin JH, Soiffer RJ, Ritz J (2005) Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 106:2903\u20132911","journal-title":"Blood"},{"key":"3062_CR6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","volume":"108","author":"K Rezvani","year":"2006","unstructured":"Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J, Keyvanfar K, Montero A, Hensel N, Kurlander R, Barrett AJ (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108:1291\u20131297","journal-title":"Blood"},{"key":"3062_CR7","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","volume":"9","author":"M Edinger","year":"2003","unstructured":"Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9:1144\u20131150","journal-title":"Nat Med"},{"key":"3062_CR8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bmt.1705628","volume":"39","author":"JJA Coenen","year":"2007","unstructured":"Coenen JJA, Koenen HJPM, van Rijssen E, Kasran A, Boon L, Hilbrands LB, Joosten I (2007) Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells. Bone Marrow Transplant 39:537\u2013545","journal-title":"Bone Marrow Transplant"},{"key":"3062_CR9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1182\/blood-2007-01-069294","volume":"110","author":"FM Marty","year":"2007","unstructured":"Marty FM, Bryar J, Browne SK, Schwarzberg T, Ho VT, Bassett IV, Koreth J, Alyea EP, Soiffer RJ, Cutler CS, Antin JH, Baden LR (2007) Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. Blood 110:490\u2013500","journal-title":"Blood"},{"key":"3062_CR10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/bmt.2011.104","volume":"47","author":"L Johnston","year":"2012","unstructured":"Johnston L, Florek M, Armstrong R, McCune JS, Arai S, Brown J, Laport G, Lowsky R, Miklos D, Shizuru J, Sheehan K, Lavori P, Negrin R (2012) Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. Bone Marrow Transplant 47:581\u2013588","journal-title":"Bone Marrow Transplant"},{"key":"3062_CR11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bmt.2008.377","volume":"43","author":"M Schleuning","year":"2009","unstructured":"Schleuning M, Judith D, Jedlickova Z, St\u00fcbig T, Heshmat M, Baurmann H, Schwerdtfeger R (2009) Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study. Bone Marrow Transplant 43:717\u2013723","journal-title":"Bone Marrow Transplant"},{"key":"3062_CR12","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1016\/j.bbmt.2015.11.771","volume":"22","author":"N Bejanyan","year":"2016","unstructured":"Bejanyan N, Rogosheske J, Defor TE, Holtan S, Jacobson P, MacMillan ML, Verneris MR, Arora M, Lazaryan A, Blazar BR, Weisdorf DJ, Wagner JE, Brunstein CG (2016) Sirolimus\/mycophenolate mofetil (MMF): effective calcineurin inhibitor-free gvhd prophylaxis for reduced Intensity conditioning (RIC) umbilical cord blood (UCB) transplantation. Biol Blood Marrow Transplant Elsevier 22:S305","journal-title":"Biol Blood Marrow Transplant Elsevier"},{"key":"3062_CR13","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1200\/JCO.2005.07.061","volume":"23","author":"C Schmid","year":"2005","unstructured":"Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb H-J (2005) Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol Off J Am Soc Clin Oncol 23:5675\u20135687","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3062_CR14","first-page":"3108","volume":"109deeg","author":"C Cutler","year":"2007","unstructured":"Cutler C, Li S, Ho VT, Koreth J, Alyea E, Soiffer RJ, Antin JH (2007) Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation. Blood Am Soc Hematol 109deeg:3108\u20133114","journal-title":"Blood Am Soc Hematol"},{"key":"3062_CR15","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2003-02-0489","volume":"102","author":"JH Antin","year":"2003","unstructured":"Antin JH, Kim HT, Cutler C, Ho VT, Lee SJ, Miklos DB, Hochberg EP, Wu CJ, Alyea EP, Soiffer RJ (2003) Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. Blood 102:1601\u20131605","journal-title":"Blood"},{"key":"3062_CR16","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2008-07-169342","volume":"112","author":"C Cutler","year":"2008","unstructured":"Cutler C, Stevenson K, Kim HT, Richardson P, Ho VT, Linden E, Revta C, Ebert R, Warren D, Choi S, Koreth J, Armand P, Alyea E, Carter S, Horowitz M, Antin JH, Soiffer R (2008) Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. Blood 112:4425\u20134431","journal-title":"Blood"},{"key":"3062_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbmt.2008.11.004","volume":"15","author":"U Platzbecker","year":"2009","unstructured":"Platzbecker U, von Bonin M, Goekkurt E, Radke J, Binder M, Kiani A, Stoehlmacher J, Schetelig J, Thiede C, Ehninger G, Bornh\u00e4user M (2009) Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 15:101\u2013108","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"3062_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","volume":"374","author":"N Kr\u00f6ger","year":"2016","unstructured":"Kr\u00f6ger N, Solano C, Wolschke C, Bandini G, Patriarca F, Pini M, Nagler A, Selleri C, Risitano A, Messina G, Bethge W, de Oteiza JP, Duarte R, Carella AM, Cimminiello M, Guidi S, Finke J, Mordini N, Ferra C, Sierra J, Russo D, Petrini M, Milone G, Benedetti F, Heinzelmann M, Pastore D, Jurado M, Terruzzi E, Narni F, V\u00f6lp A, Ayuk F, Ruutu T, Bonifazi F (2016) Antilymphocyte globulin for prevention of chronic graft-versus-host disease. N Engl J Med 374:43\u201353","journal-title":"N Engl J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3062-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T13:16:36Z","timestamp":1602508596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3062-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,15]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3062"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3062-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,15]]}}}